In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin
- 1 January 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (1), 233-238
- https://doi.org/10.1128/aac.36.1.233
Abstract
Ro 09-1227 is a novel 7-position catechol-substituted parenteral cephalosporin that also has a 3-position radical similar to previously described cephems. The Ro 09-1227 spectrum was slightly wider than that of ceftazidime against members of the family Enterobacteriaceae tested, principally because of greater activity against species producing Richmond-Sykes type I beta-lactamases. Ro 09-1227 was also more active than ceftazidime against some strains producing extended-spectrum plasmid-encoded beta-lactamases, such as TEM-3, -4, -5, -6, -7, and -9, SHV-2 and -3, and CAZ-2. Most strains of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Acinetobacter spp. were also more susceptible to Ro 09-1227 than cefotaxime, ceftriaxone, cefoperazone, and ceftazidime. Haemophilus influenzae (MIC for 90% of strains tested [MIC90], 0.5 micrograms/ml), Neisseria gonorrhoeae (MIC90, 0.015 micrograms/ml), and Moraxella (Branhamella) catarrhalis (MIC90, 0.5 micrograms/ml) were also Ro 09-1227 susceptible. Ro 09-1227 activity against important gram-positive cocci was most comparable to that of ceftazidime. Bacteroides fragilis (MIC90, greater than 32 micrograms/ml) and the enterococci (MIC90, greater than 32 micrograms/ml) were resistant to Ro 09-1227. These in vitro results indicate that this catechol-substituted cephalosporin may be useful as an empiric agent, especially for some isolates resistant to currently available broad-spectrum cephalosporins.Keywords
This publication has 9 references indexed in Scilit:
- In vitro evaluation of GR69153, a novel catechol-substituted cephalosporinAntimicrobial Agents and Chemotherapy, 1991
- In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activityAntimicrobial Agents and Chemotherapy, 1991
- Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport systemAntimicrobial Agents and Chemotherapy, 1990
- Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporinsAntimicrobial Agents and Chemotherapy, 1988
- Bactericidal activity of M14659 enhanced in low-iron environmentsAntimicrobial Agents and Chemotherapy, 1988
- E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport systemAntimicrobial Agents and Chemotherapy, 1987
- In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- Centrifugal analysis for serum iron and iron-binding capacity using the IL multistat III analyzerClinical Biochemistry, 1982
- The Significance of Iron in InfectionClinical Infectious Diseases, 1981